XML 38 R28.htm IDEA: XBRL DOCUMENT v3.21.1
Revenue Recognition (Tables)
3 Months Ended
Mar. 31, 2021
Revenue from Contract with Customer [Abstract]  
Disaggregation of Revenue [Table Text Block]
Three months ended March 31, 2021U.S. OperationsSwiss OperationsWestern European OperationsChinese OperationsOther OperationsTotal
Product Revenue$205,191 $30,167 $136,899 $143,325 $111,333 $626,915 
Service Revenue:
Point in time
51,591 6,891 35,630 9,342 27,877 131,331 
Over time
15,177 2,223 19,821 3,407 5,516 46,144 
Total$271,959 $39,281 $192,350 $156,074 $144,726 $804,390 
Three months ended March 31, 2020U.S. OperationsSwiss OperationsWestern European OperationsChinese OperationsOther OperationsTotal
Product Revenue$177,436 $24,276 $105,877 $90,321 $91,424 $489,334 
Service Revenue:
Point in time
50,234 5,557 31,391 7,106 25,676 119,964 
Over time
13,739 2,064 16,057 3,172 4,832 39,864 
Total$241,409 $31,897 $153,325 $100,599 $121,932 $649,162 
    A breakdown of net sales to external customers by geographic customer destination for the three months ended March 31 follows:
20212020
Americas$303,339 $264,824 
Europe241,377 194,828 
Asia / Rest of World259,674 189,510 
Total$804,390 $649,162 

The Company's global revenue mix by product category is laboratory (55% of sales), industrial (39% of sales) and retail (6% of sales). The Company's product revenue by reportable segment is proportionately similar to the Company's global mix except the Company's Swiss Operations is largely comprised of laboratory products, while the Company's Chinese Operations has a slightly higher percentage of industrial products. A breakdown of the Company’s sales by product category for the three months ended March 31 follows:
20212020
Laboratory$444,627 $357,091 
Industrial310,777 252,355 
Retail48,986 39,716 
Total$804,390 $649,162